To achieve this, comprehensive literature analysis was performed using recent peer-reviewed publications, with emphasis on mechanistic, preclinical, and therapeutic data that collectively illustrate the evolving understanding of Nrf2 as a promising target in IBD management. Here, NFE2L2 is linked to inflammatory bowel disease.